Rationale and Design of the ADIDAS Study: Association Between Dapagliflozin-Induced Improvement and Anemia in Heart Failure Patients

BACKGROUND: Heart failure (HF) is one of the most serious health concerns worldwide. Anemia is a highly prevalent comorbidity and outcome predictor in HF patients. Sodium glucose co-transport 2 (SGLT2) inhibitors have been demonstrated to reduce the risk of cardiovascular death and HF hospitalizatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Jianping, Zhu, Yunlong, Zhao, Wenjiao, Wu, Mingxing, Huang, Haobo, Huang, He, Wu, ChunFeng, Zhou, XiaoLin, Zhou, ShengHua, Wang, ChengMing, Yin, Kai, Xu, FangHua, Cai, ZhiQiang, Li, Xinyang, Cheng, Huiheng, Xie, Youwen, Tan, Zhuqing, Hu, Xiaoyong, Liao, Dexiang, Wang, Yingchun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Trial Designs
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9090851/
https://www.ncbi.nlm.nih.gov/pubmed/33779938
http://dx.doi.org/10.1007/s10557-021-07176-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9090851/
https://www.ncbi.nlm.nih.gov/pubmed/33779938
http://dx.doi.org/10.1007/s10557-021-07176-0

Ejemplares similares